Mecorik-G Tablet is a combination pharmaceutical formulation containing Gabapentin 300 mg and Methylcobalamin 500 mcg, designed for the management of neuropathic pain and peripheral neuropathies. Gabapentin, an anticonvulsant agent, modulates neuronal excitability by binding to the alpha-2-delta subunit of voltage-gated calcium channels, thereby reducing neurotransmitter release and alleviating neuropathic pain symptoms. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair by promoting myelin sheath synthesis and enhancing neuronal function. The synergistic action of these components makes Mecorik-G effective in treating conditions such as diabetic neuropathy, postherpetic neuralgia, and other neuropathic disorders. It is also beneficial in improving nerve conduction and reducing symptoms like numbness, tingling, and burning sensations. Mecorik-G is typically administered orally, with dosage and duration tailored according to clinical response and physician guidance. Common side effects may include dizziness, somnolence, and gastrointestinal discomfort, although it is generally well tolerated. Caution is advised in patients with renal impairment, and dose adjustments may be necessary. Mecorik-G should be used under medical supervision to ensure optimal therapeutic outcomes and minimize adverse effects.